Yihong Health, a medical testing products and services provider, recently completed a new round of funding worth tens of millions of CNY. This round of funding was led by Kinzon Capital, followed by Joy Capital.
Yihong Health, which was founded in 2014, focuses on the research and development of a new generation of (Integrated Point-of-Care Testing) iPOCT products that combine artificial intelligence and mobile internet technology. Yihong Health currently provides over 30,000 primary medical institutions with comprehensive services based on iPOCT products.
The company has progressed in POCT product research and development, with positive results ,according to reports. It has created a new line of iPOCT products, including its own test strips and hematology analyzers. Aside from the advantages of the POCT product (Point-of-Care Testing), Yihong's iPOCT products combine mobile internet and artificial intelligence to update detection program in a single click.
Yihong Health's hematology analyzer is China's first dry hematology analyzer with cell imaging that can be used in the clinical stage, and with the approval of the China Institute for Food and Drug Control. This Analyzer, as opposed to a transitional hematology analyzer, can eliminate the risks of plugging holes, liquid leakage, cross-contamination, and other issues. At the same time, there is no liquid waste produced by this hematology analyzer, and maintenance costs are low, allowing for intelligent quality management.